A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis

Condition:   Moderate to Severe Ulcerative Colitis Interventions:   Drug: 50 mg;   Drug: 450 mg;   Drug: 150 mg;   Other: 0 mg Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials